About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT05822089

Intraindividual Comparison of EMO IOLs

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surge...

Lead sponsor: Medical University of Vienna•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Christina Leydolt, MD

CONTACT

+43 (01) 40 400 79480 christina.leydolt@meduniwien.ac.at

Sponsors

Lead Sponsor

Medical University of Vienna

Age

50 - 100 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Bilateral age-related cataract planned for phacoemulsification extraction and posterior IOL implantation
•Age 50 to 100
•Visual potential in both eyes of 20/25 or better as determined by investigators estimation
•Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
•Irregular Astigmatism (Acrysof IQ Vivity IOL, IC-8 Apthera IOL)
•postoperativ binocular best corrected distance visual acuity (BCVA) ≥ 1.0 decimal (Arm ten (X))
•Standard cataract surgery with bilateral implantation of a monofocal IOL (Vivinex XC1 or Vivinex XY1) (Arm ten (X))

Exclusion Criteria

•Preceding intraocular surgery or ocular trauma
•Relevant other ophthalmic diseases that particularly effects the zonular apparatus (such as severe pseudoexfoliation syndrome, preceding cryocoagulation, trauma)
•Pupil diameter \< 2.0 mm (photopic)
•Laser treatment
•Uncontrolled systemic or ocular disease
•Pregnancy/Nursing
•childbearing ability

Related studies

Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens

NCT07006428 · Age Related Cataracts

Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric

NCT03803852 · Age Related Cataracts, Astigmatism

Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.

NCT03903965 · Diabetes Mellitus Type 2, Age Related Cataracts

Evaluation of Physiological Responses at the Anterior Surface of Two (Hydrophobic Acrylic) Intraocular Lens Models

NCT04230629 · Age Related Cataracts

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 5, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment461

Start dateDec 2021

Last updatedDec 5, 2025

Condition

Age Related Cataracts

Locations shown

Medical University of Vienna

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 5, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions